C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2011
12/28/2011	EP2398794A1 Hepatitis c virus inhibitors
12/28/2011	EP2398793A1 Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
12/28/2011	EP2398791A1 INDOLE/BENZIMIDAZOLE COMPOUNDS AS mTOR KINASE INHIBITORS
12/28/2011	EP2398777A1 Pyrimidopyridazine derivatives useful as p38 mapk inhibitors
12/28/2011	EP2398775A1 Coupled recognition/detection system for in vivo and in vitro use
12/28/2011	EP2398769A1 Novel ortho-aminoamides for the treatment of cancer
12/28/2011	EP2398768A1 Pyrrolidine derivatives as nk3 receptor antagonists
12/28/2011	EP2398474A1 Inhibitors of hcv ns5a
12/28/2011	EP2205560B1 Azabicyclo [3. 1. 0]hexyl derivatives as modulators of dopamine d3 receptors
12/28/2011	EP1697348B1 Hiv protease inhibiting compounds
12/28/2011	CN1930135B 作为P2X<sub>3</sub>和P2X<sub>2/3</sub>拮抗剂的二氨基嘧啶 As P2X <sub> 3 </ sub> and P2X <sub> 2/3 </ sub> antagonists diaminopyrimidines
12/28/2011	CN102300862A 用作atr激酶抑制剂的化合物 Compounds useful as kinase inhibitors atr
12/28/2011	CN102300860A 作为磷酸二酯酶10抑制剂的吡嗪类化合物 As a phosphodiesterase inhibitor compound 10 pyrazines
12/28/2011	CN102300845A 用于治疗癌症的新型邻氨基酰胺类 Anthranilic acid amides for the new cancer treatment
12/28/2011	CN102295640A 3-杂环席夫碱-5-氟-吲哚-2-酮类化合物及其制备方法和应用 3- 5-fluoro-heterocyclic Schiff base - indole-2-ketone compound and preparation method and application
12/28/2011	CN101792440B 喹唑啉酮衍生物及其制备和应用 Quinazolinone derivatives, preparation and application
12/28/2011	CN101781265B 氨基酸与农药的藕合物及其制备方法与作为农药的应用 Amino acids coupled with the pesticide and its preparation method and use as pesticides
12/28/2011	CN101723909B 三唑酮类化合物、其制备方法和用途 Triazolone compounds, their preparation and use
12/28/2011	CN101679306B 治疗神经变性疾病的杂芳基酰胺取代的嘧啶酮衍生物 Treatment of neurodegenerative diseases heteroaryl amide substituted pyrimidone derivatives
12/27/2011	US8084620 Carbazole carboxamide compounds useful as kinase inhibitors
12/27/2011	US8084618 Heterocyclic compounds and methods of use
12/27/2011	US8084607 Apoptosis promoters
12/27/2011	US8084466 Bicyclic heteroaryl-substituted imidazoles as modulators of the histamine H4 receptor
12/27/2011	US8084459 Substituted quinazolinones for treating neurological conditions
12/27/2011	US8084457 Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases
12/27/2011	US8084456 Pyrazine-based tubulin inhibitors
12/27/2011	US8084442 N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors
12/27/2011	US8084398 Benzoylpyrazoles and herbicide
12/27/2011	US8083965 Refrigerating machine oil
12/22/2011	WO2011160020A2 Carbapenem antibacterials with gram-negative activity
12/22/2011	WO2011159857A1 Carboline carboxamide compounds useful as kinase inhibitors
12/22/2011	WO2011159854A1 Cyclohexyl-azetidinyl antagonists of ccr2
12/22/2011	WO2011159302A1 Arylindenopyrimidines for treating neurodegenerative and movement disorders while minimizing cardiac toxicity
12/22/2011	WO2011158833A1 Agent for treating hcv infection
12/22/2011	WO2011158255A1 Process for preparation of stable imatintb mesylate alpha form
12/22/2011	WO2011158149A1 2-(3,5-disubstitutedphenyl)pyrimidin-4(3h)-one derivatives
12/22/2011	WO2011157787A1 Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
12/22/2011	WO2011157653A1 Anthranilic acid derivatives
12/22/2011	WO2011157651A1 Anthranilic acid diamide derivatives with cyclical side chains
12/22/2011	WO2011123947A8 Synthesis of chiral 2-(1h-indazol-6-yl)-spiro[cyclopropane-1,3'- indolin]-2'-ones
12/22/2011	WO2011097594A3 Therapeutic methods and compositions involving allosteric kinase inhibition
12/22/2011	WO2010139967A8 Dihydroindole and tetrahydroisoquinoline derivatives useful as potassium channel inhibitors
12/22/2011	WO2010096426A8 Compounds, compositions, methods of synthesis, and methods of treatment
12/22/2011	US20110313174 Trianionic pincer ligands, a cr(iii)/cr(v) catalytic system and its use for catalytic aerobic oxidation of organic substrates
12/22/2011	US20110313173 Process for producing acrylonitrile compound
12/22/2011	US20110313156 Heterocyclyl carbonic acid amides as antiproliferative agents, pdkl inhibitors
12/22/2011	US20110313129 Large stokes shift dyes
12/22/2011	US20110313001 Triazole derivatives for treatment of alzheimer's disease
12/22/2011	US20110312996 Novel inhibitors of hepatitis c virus replication
12/22/2011	US20110312989 Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
12/22/2011	US20110312977 Process for the preparation of voriconazole
12/22/2011	US20110312969 Compounds for treating cancer
12/22/2011	US20110312963 P38 map kinase inhibitors
12/22/2011	US20110312953 Anthranilic acid derivatives
12/22/2011	US20110312949 Pharmaceutical use of substituted amides
12/22/2011	US20110312945 Crth2 modulators
12/22/2011	US20110312944 Heterocyclic Compounds Which Modulate The CB2 Receptor
12/22/2011	US20110312936 Cyclohexyl-azetidinyl antagonists of ccr2
12/22/2011	US20110312935 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents
12/22/2011	US20110312931 Glycine transporter-1 inhibitors, methods of making them, and uses thereof
12/22/2011	US20110312904 Compounds, compositions and methods for reducing toxicity and treating or preventing diseases
12/22/2011	US20110312890 Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements
12/22/2011	US20110311593 N-hydroxylated amidine-, guanidine- and/or aminohydrazone-type prodrugs for application on the skin
12/22/2011	US20110311483 Crth2 modulators
12/22/2011	US20110311482 Hepatitis C Virus Inhibitors
12/22/2011	US20110309345 Compound for organic electroluminescent device and organic electroluminescent device having the same
12/22/2011	US20110309338 Materical for organic electroluminescent devices and organic electroluminescent devices made by using the same
12/22/2011	DE102010030187A1 New 4-cyano-2-sulfonylphenyl-pyrazolyl-substituted pyridinones and pyrazinones compounds are human neutrophil elastase inhibitors, useful to treat and prevent e.g. pulmonary arterial hypertension and chronic obstructive pulmonary disease
12/22/2011	DE102010023959A1 Neue Verbindungen als Liganden für Übergangsmetallkomplexe und daraus hergestellte Materialien, sowie Verwendung dazu New compounds as ligands for transition metal complexes and derived materials, and use this
12/22/2011	CA2802529A1 Carbapenem antibacterials with gram-negative activity
12/22/2011	CA2802477A1 Agent for treating hcv infection
12/22/2011	CA2801934A1 Cyclohexyl-azetidinyl antagonists of ccr2
12/21/2011	EP2397480A1 Diazepinedione derivative
12/21/2011	EP2397479A1 Hetero ring derivative
12/21/2011	EP2397476A2 Indole derivative having PGD2 receptor antagonist activity
12/21/2011	EP2397471A1 Benzimidazole compounds and their use
12/21/2011	EP2397469A1 Diarylhydantoin compounds
12/21/2011	EP2396318A2 Large stokes shift dyes
12/21/2011	EP2396317A1 Crystalline polymorphic form 631
12/21/2011	EP2396316A1 Quinazolinones as prolyl hydroxylase inhibitors
12/21/2011	EP2396314A1 Process for preparation of bezoyl amino heterocyclyl compounds
12/21/2011	EP2396307A1 Novel amino azaheterocyclic carboxamides
12/21/2011	EP2396304A1 Triazole and imidazole derivatives for use as tgr5 agonists in the treatment of diabetes and obesity
12/21/2011	EP2396004A1 Selective kinase inhibitors
12/21/2011	EP2395835A1 Agonists and antagonists of the sip5 receptor, and methods of uses thereof
12/21/2011	EP2217580B1 Substituted tetrazole compounds and uses thereof
12/21/2011	EP2091922B1 2-[1-phenyl-5-hydroxy-4alpha-methyl-hexahydrocyclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands
12/21/2011	EP1567503B1 Pyrazole derivatives useful as cox-i inhibitors
12/21/2011	CN102292338A 酪氨酸激酶蛋白受体拮抗剂 Protein tyrosine kinase receptor antagonist
12/21/2011	CN102292329A 布鲁顿酪氨酸激酶的抑制剂 Bruton tyrosine kinase inhibitors
12/21/2011	CN102292328A 具有cb2受体激动活性的n-取代饱和杂环砜化合物 Agonistic activity n- receptor having cb2 substituted saturated heterocyclic sulfone compound
12/21/2011	CN102292323A 芳基甲基苯并喹唑啉酮m1受体正向变构调节剂 Aryl methylbenzo -quinazolinon m1 receptor positive allosteric modulator
12/21/2011	CN102292322A 用于治疗例如癌症的疾病的取代的嘧啶 Substituted pyrimidines for the treatment of diseases such as cancer
12/21/2011	CN102285971A 吡唑基喹唑啉酮类化合物及其应用 Pyrazolyl quinazolinone compounds and uses thereof
12/21/2011	CN101775007B 具有hiv拮抗活性的三环烯类化合物及其制备方法与应用 Tricyclic diene compound and its preparation method and application hiv antagonistic activity
12/21/2011	CN101486683B 哒嗪酮和三嗪酮化合物及其作为药物制剂的用途 Pyridazinone and triazinone compounds and their use as pharmaceutical preparations
12/21/2011	CN101242848B 嘧啶化合物 Pyrimidine compounds
12/20/2011	US8080666 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
12/20/2011	US8080659 CXCR4 antagonists including diazine and triazine structures for the treatment of medical disorders
12/20/2011	US8080573 Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors

1 ... 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 ... 626